Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Levonorgestrel - Gedeon Richter

X
Drug Profile

Levonorgestrel - Gedeon Richter

Alternative Names: Plan B; Plan B One-Step

Latest Information Update: 28 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Gedeon Richter; World Health Organization
  • Developer Gedeon Richter
  • Class Hormonal contraceptives; Hormonal replacements; Norpregnanes; Progesterone congeners; Small molecules
  • Mechanism of Action Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pregnancy

Most Recent Events

  • 07 Aug 2013 Plan B® One-Step is now available as an OTC product with no age or point-of-sale restriction in the US
  • 21 Jun 2013 Plan B® One-Step is approved as an OTC product with no age or point-of-sale restriction in the US
  • 12 Jun 2013 Generic equivalent from Gavis Pharmaceuticals (My Way™, levonogestrel 1.5mg) is available OTC without a prescription in USA for women aged 17 and older

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top